School of Medicine
Showing 1-9 of 9 Results
-
Kristin Jensen
Associate Professor of Pathology at the Palo Alto Veteran's Health Care System and at Stanford University Medical Center
Current Research and Scholarly InterestsI am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology.
-
Rohan Prakash Joshi
Instructor, Pathology
BioDr. Joshi is an instructor in molecular pathology, with training in clinical data science, molecular pathology, and clinical pathology. His clinical focus is molecular diagnostics for solid and hematologic neoplasms, and as part of Stanford Medicine's Molecular Genetic Pathology laboratory, Dr. Joshi has developed bioinformatic tools to monitor tumor mutation burden and gene/chromosome copy number variation from focused targeted sequencing panels. Dr. Joshi's research focuses on understanding the tumor-immune microenvironment by developing tools that connect underlying next-generation sequencing findings to computational image microscopy phenotypes.
-
Yun Shin Jung
Postdoctoral Research Fellow, Pathology
BioDr. Jung received her B.S. in Medical Science from University Sydney in Australia and completed her Ph.D. in Human Biology at University of Tsukuba in Japan. Following her Ph.D., she has joined Dr. Katrin J Svensson's lab in Stanford for her postdoctoral training, in the field of molecular endocrinology and metabolism. Her research focus is especially in understanding of fatty liver disease.
-
Marisa Juntilla
Adjunct Clinical Assistant Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to reveal novel biology in leukemia that links cancer cell metabolism to protein translation, ultimately providing new opportunities for personalized medicine and reduced chemotherapeutic toxicity.
